Patients 80 years of age and older experienced a 31% reduction in mortality and a 20% reduction in the risk of new coronary events when they participated in statin therapy, according to a March study ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s a math problem with life-and-death ...

Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...

Most people surveyed wouldn't be willing to take statins at their actual efficacy levels in primary prevention, according to a study with implications for shared decision-making. When informed about ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...

EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...

Discontinuing statins before pregnancy does not increase maternal cardiovascular risk, even in patients with pre-existing atherosclerotic disease.

Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop. The long list of side effects, detailed in fine print on package ...

The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...

2024 NOV 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily-- Fresh data on Managed Care are presented in a new report. According to news reporting originating from ...